Alaska Permanent Fund’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-26,188
Closed -$3.7M – 71
2025
Q1
$3.7M Hold
26,188
– – 0.05% 137
2024
Q4
$3.1M Hold
26,188
– – 0.05% 195
2024
Q3
$2.89M Hold
26,188
– – 0.04% 219
2024
Q2
$2.64M Buy
26,188
+223
+0.9% +$22.7K 0.04% 253
2024
Q1
$2.91M Buy
25,965
+4,870
+23% +$525K 0.04% 182
2023
Q4
$2.13M Buy
21,095
+5,804
+38% +$576K 0.04% 298
2023
Q3
$1.33M Buy
+15,291
New +$1.38M 0.03% 329
2022
Q4
$3.61M Hold
47,000
– – 0.06% 103
2022
Q3
$3.13M Hold
47,000
– – 0.06% 95
2022
Q2
$2.46M Buy
47,000
+2,000
+4% +$114K 0.04% 114
2022
Q1
$2.55M Hold
45,000
– – 0.04% 117
2021
Q4
$2.32M Hold
45,000
– – 0.04% 149
2021
Q3
$2.23M Hold
45,000
– – 0.04% 170
2021
Q2
$2.57M Sell
45,000
-3,300
-7% -$193K 0.05% 66
2021
Q1
$2.93M Hold
48,300
– – 0.05% 155
2020
Q4
$2.59M Hold
48,300
– – 0.05% 165
2020
Q3
$2.27M Buy
48,300
+28,450
+143% +$1.46M 0.04% 70
2020
Q2
$1.04M Hold
19,850
– – 0.02% 57
2020
Q1
$952K Buy
+19,850
New +$1.03M 0.02% 46

Other funds holding CAH

Alaska Permanent Fund's CAH Position: Q2 2025 in Review

Alaska Permanent Fund sold out of Cardinal Health (CAH) in Q2 2025, closing a stake of 26,188 shares — an estimated $3.7M sold.

Alaska Permanent Fund first reported a position in CAH in Q1 2020 and held it in 19 quarters. The position peaked at $3.7M in Q1 2025. 1,254 funds tracked by Wall St. Rank hold CAH as of Q2 2025.

  • Alaska Permanent Fund reported no remaining Cardinal Health position as of Q2 2025 after selling out during the quarter.
  • Alaska Permanent Fund sold 26,188 Cardinal Health shares in Q2 2025, an estimated $3.7M.
  • Alaska Permanent Fund first reported a position in Cardinal Health in Q1 2020 and held it in 19 quarters.
  • Alaska Permanent Fund's Cardinal Health position peaked at $3.7M in Q1 2025.
  • 1,254 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2025.

Based on Alaska Permanent Fund's 13F filing for Q2 2025, filed 14 Aug 2025.